| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |